These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20638108)

  • 21. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
    Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
    Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes.
    del Valle J; Feliubadaló L; Nadal M; Teulé A; Miró R; Cuesta R; Tornero E; Menéndez M; Darder E; Brunet J; Capellà G; Blanco I; Lázaro C
    Breast Cancer Res Treat; 2010 Aug; 122(3):733-43. PubMed ID: 19894111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1 mutation analysis in breast/ovarian cancer families from Greece.
    Konstantopoulou I; Kroupis C; Ladopoulou A; Pantazidis A; Boumba D; Lianidou ES; Petersen MB; Florentin L; Chiotellis E; Nounesis G; Efstathiou E; Skarlos D; Tsionou C; Fountzilas G; Yannoukakos D
    Hum Mutat; 2000 Sep; 16(3):272-3. PubMed ID: 10980541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families.
    Hartmann C; John AL; Klaes R; Hofmann W; Bielen R; Koehler R; Janssen B; Bartram CR; Arnold N; Zschocke J
    Hum Mutat; 2004 Dec; 24(6):534. PubMed ID: 15532023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
    Egeli U; Cecener G; Tunca B; Tasdelen I
    Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
    Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
    Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
    Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
    Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
    Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
    Sarantaus L; Vahteristo P; Bloom E; Tamminen A; Unkila-Kallio L; Butzow R; Nevanlinna H
    Eur J Hum Genet; 2001 Jun; 9(6):424-30. PubMed ID: 11436123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
    Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
    Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA array-based method for detection of large rearrangements in the BRCA1 gene.
    Frolov A; Prowse AH; Vanderveer L; Bove B; Wu H; Godwin AK
    Genes Chromosomes Cancer; 2002 Nov; 35(3):232-41. PubMed ID: 12353265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay.
    Manguoğlu E; Güran S; Yamaç D; Simşek M; Akdeniz S; Colak T; Gülkesen H; Lüleci G
    Cancer Invest; 2011 Jan; 29(1):73-7. PubMed ID: 20919953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families.
    Woodward AM; Davis TA; Silva AG; Kirk JA; Leary JA;
    J Med Genet; 2005 May; 42(5):e31. PubMed ID: 15863663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.
    Yazici H; Glendon G; Yazici H; Burnie SJ; Saip P; Buyru F; Bengisu E; Andrulis IL; Dalay N; Ozcelik H
    Hum Mutat; 2002 Jul; 20(1):28-34. PubMed ID: 12112655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
    Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
    Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
    Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
    Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-founder BRCA1 mutations in Russian breast cancer patients.
    Iyevleva AG; Suspitsin EN; Kroeze K; Gorodnova TV; Sokolenko AP; Buslov KG; Voskresenskiy DA; Togo AV; Kovalenko SP; Stoep Nv; Devilee P; Imyanitov EN
    Cancer Lett; 2010 Dec; 298(2):258-63. PubMed ID: 20727672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.